Variant report

Variant	nsv1002863
Chromosome Location	chr2:49575829-49650145
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:49586512..49588631-chr2:49595229..49597558,2	K562	blood:
2	chr2:49586512..49588631-chr2:49595229..49597558,2	K562	blood:

Extended variants
information (count: 993 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:993 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371821698	chr2:49578835-49578836	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs543061236	chr2:49578878-49578879	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs539213290	chr2:49578893-49578894	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs860133	chr2:49578937-49578938	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs550381010	chr2:49578940-49578941	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs181009502	chr2:49579015-49579016	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs35962504	chr2:49579028-49579029	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs817083	chr2:49579034-49579035	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs148163570	chr2:49579121-49579122	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs186328657	chr2:49579142-49579143	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs554297098	chr2:49579174-49579175	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs535870523	chr2:49579225-49579226	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs554593527	chr2:49579244-49579245	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs569640115	chr2:49579326-49579327	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs140163136	chr2:49579346-49579347	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs536780284	chr2:49579361-49579362	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs558303934	chr2:49579434-49579435	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs189998099	chr2:49579453-49579454	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs572471305	chr2:49579480-49579481	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs540889383	chr2:49579497-49579498	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs369498089	chr2:49579508-49579509	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs181227459	chr2:49579554-49579555	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs369143939	chr2:49579586-49579587	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs542646924	chr2:49579603-49579604	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs543113168	chr2:49579612-49579613	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs561369423	chr2:49579739-49579740	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs141394403	chr2:49579787-49579788	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs115753022	chr2:49580895-49580896	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs542112074	chr2:49580909-49580910	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187629882	chr2:49580934-49580935	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs143701999	chr2:49580977-49580978	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs147219436	chr2:49580997-49580998	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs531537286	chr2:49583209-49583210	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs149031774	chr2:49583217-49583218	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs143041149	chr2:49583237-49583238	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs373369888	chr2:49583265-49583266	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs533225225	chr2:49583332-49583333	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs374782528	chr2:49583335-49583336	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs535852545	chr2:49583351-49583352	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs188865019	chr2:49583359-49583360	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181718285	chr2:49583362-49583363	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs817071	chr2:49583402-49583403	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs148215306	chr2:49583408-49583409	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs187154735	chr2:49583447-49583448	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs538567372	chr2:49583500-49583501	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs192125605	chr2:49583510-49583511	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs182142956	chr2:49583511-49583512	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs538688022	chr2:49583515-49583516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs553590488	chr2:49583541-49583542	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs543464131	chr2:49583568-49583569	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Basal cell lymphoma	21115979	CNVD

Chromatin state (count:75 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:49578800-49579800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr2:49580800-49581000	Bivalent Enhancer	Aorta	Aorta
3	chr2:49580800-49581000	Enhancers	Lung	lung
4	chr2:49583200-49583400	Enhancers	H1 Cell Line	embryonic stem cell
5	chr2:49583200-49583400	Enhancers	iPS-15b Cell Line	embryonic stem cell
6	chr2:49583400-49586400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr2:49583400-49587600	Weak transcription	H1 Cell Line	embryonic stem cell
8	chr2:49585400-49585600	Enhancers	Fetal Brain Female	brain
9	chr2:49585600-49586600	Weak transcription	Fetal Brain Female	brain
10	chr2:49586400-49587800	Enhancers	iPS-15b Cell Line	embryonic stem cell
11	chr2:49586400-49588000	Enhancers	Fetal Brain Male	brain
12	chr2:49586600-49587200	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr2:49586600-49587600	Enhancers	Fetal Brain Female	brain
14	chr2:49586600-49588000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr2:49586600-49588800	Enhancers	Brain Germinal Matrix	brain
16	chr2:49587000-49587400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr2:49587000-49587800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr2:49587000-49588000	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr2:49587000-49588000	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr2:49587200-49587800	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr2:49587200-49588000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr2:49587400-49587800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
23	chr2:49587600-49588000	Enhancers	H1 Cell Line	embryonic stem cell
24	chr2:49587800-49588000	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr2:49593000-49593200	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr2:49593200-49593800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr2:49593800-49594200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr2:49594000-49594400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr2:49594200-49594800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr2:49594400-49595400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr2:49594400-49597600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr2:49594800-49595400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr2:49595400-49596200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr2:49595600-49595800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr2:49596000-49596400	Enhancers	Fetal Brain Female	brain
36	chr2:49596200-49598600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr2:49596800-49597000	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr2:49597000-49598000	Weak transcription	HUES48 Cell Line	embryonic stem cell
39	chr2:49597000-49598000	Enhancers	iPS-18 Cell Line	embryonic stem cell
40	chr2:49597600-49598000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
41	chr2:49598000-49598400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
42	chr2:49598000-49598600	Enhancers	HUES64 Cell Line	embryonic stem cell
43	chr2:49598000-49598800	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr2:49598200-49598400	Enhancers	iPS-20b Cell Line	embryonic stem cell
45	chr2:49598600-49601000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
46	chr2:49599000-49599200	Enhancers	iPS-20b Cell Line	embryonic stem cell
47	chr2:49601000-49601600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr2:49603400-49603800	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
49	chr2:49603800-49604400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
50	chr2:49604000-49604600	Enhancers	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links